Astellas Pharma Inc.[Grants and Funding] - Search Results

Year	Number of Results
2017	1
2018	11
2019	11
2020	10
2021	18
2022	11
2023	10
2024	18

1

Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma.

Shitara K, Kawazoe A, Hirakawa A, Nakanishi Y, Furuki S, Fukuda M, Ueno Y, Raizer J, Arozullah A. Shitara K, et al. Cancer Sci. 2023 Apr;114(4):1606-1615. doi: 10.1111/cas.15684. Epub 2022 Dec 25. Cancer Sci. 2023. PMID: 36478334 Free PMC article. Clinical Trial.

2

3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.

Lewiecki EM, Betah D, Humbert L, Libanati C, Oates M, Shi Y, Winzenrieth R, Ferrari S, Omura F. Lewiecki EM, et al. J Bone Miner Res. 2024 May 2;39(4):473-483. doi: 10.1093/jbmr/zjae028. J Bone Miner Res. 2024. PMID: 38477808 Free PMC article. Clinical Trial.

3

Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real-world data analysis.

Takahashi H, Asakawa K, Kosakai Y, Lee T, Rokuda M. Takahashi H, et al. Diabetes Obes Metab. 2024 Mar;26(3):997-1007. doi: 10.1111/dom.15399. Epub 2023 Dec 12. Diabetes Obes Metab. 2024. PMID: 38086547

4

Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials.

Cano A, Nappi RE, Santoro N, Stute P, Blogg M, English ML, Morga A, Scrine L, Siddiqui E, Ottery FD. Cano A, et al. BJOG. 2024 Aug;131(9):1296-1305. doi: 10.1111/1471-0528.17773. Epub 2024 Feb 6. BJOG. 2024. PMID: 38320967 Free article. Clinical Trial.

5

The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium-Glucose Transporter 2 Inhibitors.

Yamato M, Kato N, Yamada KI, Inoguchi T. Yamato M, et al. Diabetes. 2024 Jul 1;73(7):1153-1166. doi: 10.2337/db22-0970. Diabetes. 2024. PMID: 38608284 Free PMC article.

6

Safety and efficacy of an α₁ -blocker plus mirabegron compared with an α₁ -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.

Herschorn S, Tarcan T, Jiang YH, Chung E, Abdul Hadi F, Steup A, Sumarsono B. Herschorn S, et al. Neurourol Urodyn. 2024 Mar;43(3):604-619. doi: 10.1002/nau.25399. Epub 2024 Jan 30. Neurourol Urodyn. 2024. PMID: 38291827 Review.

7

Reconstruction of remodeling units reveals positive effects after 2 and 12 months of romosozumab treatment.

Eriksen EF, Boyce RW, Shi Y, Brown JP, Betah D, Libanati C, Oates M, Chapurlat R, Chavassieux P. Eriksen EF, et al. J Bone Miner Res. 2024 Jul 23;39(6):729-736. doi: 10.1093/jbmr/zjae055. J Bone Miner Res. 2024. PMID: 38640512 Clinical Trial.

8

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Mittelman M, Henry DH, Glaspy JA, Tombak A, Harrup R, Kim I, Mądry K, Grabowska B, Lee T, Modelska K. Mittelman M, et al. Am J Hematol. 2024 Sep;99(9):1778-1789. doi: 10.1002/ajh.27410. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884137 Clinical Trial.

9

Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database.

Ishibashi R, Inaba Y, Koshizaka M, Takatsuna Y, Tatsumi T, Shiko Y, Kashiwagi Y, Maezawa Y, Kawasaki Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Diabetes Obes Metab. 2024 Apr;26(4):1510-1518. doi: 10.1111/dom.15454. Epub 2024 Jan 19. Diabetes Obes Metab. 2024. PMID: 38240052

10

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review.

Butler J, Brown M, Prokocimer P, Humphries AC, Pope S, Wright O, Su J, Elnawasany O, Muresan B. Butler J, et al. ESC Heart Fail. 2024 Sep 18. doi: 10.1002/ehf2.15075. Online ahead of print. ESC Heart Fail. 2024. PMID: 39294891 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year